GlassScriptPhysician profile
Bharat C Patel
NPI 1457351322
$529.75
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $69.74 · 2021: $75.78 · 2022: $130 · 2023: $54.13 · 2024: $68.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $122.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $139.64 | 2021-2024 | Entyvio |
| Abbott Laboratories | $76.38 | 2022-2023 | Proclaim |
| Si-Bone, INC. | $51.44 | 2024 | |
| Allergan, INC. | $29.02 | 2019 | |
| Radius Health, INC. | $27.82 | 2021 | |
| Bioventus LLC | $24.89 | 2020 | |
| Fidia Pharma USA INC. | $24.65 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $19.27 | 2020 | |
| Vertiflex, INC. | $18.51 | 2019 | |
| Pacira Therapeutics, INC. | $17.16 | 2019 | |
| Abbvie INC. | $17.09 | 2021 | |
| Medtronic USA, INC. | $16.30 | 2019 | |
| Vertos Medical, INC. | $15.71 | 2021 | |
| Phadia US INC. | $13.29 | 2019 | |
| Pernix Therapeutics Holdings, INC. | $13.00 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $12.84 | 2020 | |
| Biodelivery Sciences International, INC. | $12.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bharat Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.